• 기술사
• /
• 제36권6호
• /
• pp.78-81
• /
• 2003

Physiologically functional food is a type of the processed foods showing bioactivities in a living body. Physiologically functional food is a healthy food reinforcing biofunctional abilities of the precaution and recovering of the illness, immunity reinforcement. bio - rhythm control, aging repression and cancer precaution, etc. The consumers are taking to expect the improvement of national health and extention of life span. etc., Physiologically functional food must be able to be ingested briefly and taken in the surroundings easily and the reasonable price. To achieve this goals, it is necessary to positive support of the authorities concerned, technique development of an educational - Industrial cooperation. establishment of reasonable standard and right understanding of the consumers on physiologically functinal food.

• 한국산림과학회지
• /
• 제84권3호
• /
• pp.361-368
• /
• 1995

표고버섯 원목(原木) 재배(栽培)에 있어서 골목화 기간을 단축하여 해균(害菌)의 침입을 막고 생산량 증대를 위한 방법으로 생리활성화물질(生理活性化物質)이 표고버섯 골목화에 미치는 영향을 실험분석하였다. 생리활성화물질은 파(Allium fistulosm), 보리(Hordeum vulagare var. hexastichon), 표고버섯(Lentinus edodes), 당근(Daucus carota var. sativa), 유자(Citrus junos)를 사용하였는데 그 중 파(Allium fistulosm)의 추출액이 제일 유효하였으며, 생리활성화물질(生理活性化物質)에 효과가 높은 수종(樹種)은 굴참나무(Quercus variabilis)로 나타났다.

• 한국조리학회지
• /
• 제5권2호
• /
• pp.401-418
• /
• 1999

Many plants and animal have long been known to have medicinal effects and therefore have been used as medicines. There are many substances that show various pharmacologic efficacy such as anti-tumor efficacy, anti-inflammatory efficacy, cholesterol-lowering efficacy, anti-coagulant of blood efficacy and anti-bacterial efficacy. I summarized the recent advances in research on physiologically functional foods. The pharmacological efficacy of dietary fiber, chitin & chitosan, DHA(docosahexaenoic acid), mushroom, alginic acid and herbs have selected as topices for discussion. I was examining the anti-coagulant activity of herbs, I discovered that Eugenia caryophyllata T. (clove) had a relatively high anti-coagulant activity.

• 약학회지
• /
• 제59권1호
• /
• pp.29-39
• /
• 2015

In recent years, physiologically based pharmacokinetic (PBPK) modeling has been widely used in pharmaceutical industries as well as regulatory health authorities for drug discovery and development. Several application areas of PBPK have been introduced so far including drug-drug interaction prediction, transporter-mediated interaction prediction, and pediatric PK prediction. The purpose of this review is to introduce PBPK and illustrates one of its application areas, particularly pediatric PK prediction by utilizing existing adult PK data and in vitro data. The evaluation of the initial PBPK for adult was done by comparing with experimental PK profiles and the scaling from adult to pediatric was conducted using age-related changes in size such as tissue compartments, and protein binding etc. Sotalol and lorazepam were selected in this review as model drugs for this purpose and were re-evaluated using the PBPK models by GastroPlus$^{(R)}$. The challenges and strategies of PBPK models using adult PK data as well as appropriate in vitro assay data for extrapolating pediatric PK at various ages were also discussed in this paper.

• Bulletin of the Korean Chemical Society
• /
• 제32권11호
• /
• pp.3967-3972
• /
• 2011

A whole body physiologically based pharmacokinetic (PBPK) model was applied to investigate absorption, distribution, and physiologic variations on pharmacokinetics of imatinib in human body. Previously published pharmacokinetic data of the drug after intravenous (i.v.) infusion and oral administration were simulated by the PBPK model. Oral dose absorption kinetics were analyzed by adopting a compartmental absorption and transit model in gut section. Tissue/plasma partition coefficients of drug after i.v. infusion were also used for oral administration. Sensitivity analysis of the PBPK model was carried out by taking parameters that were commonly subject to variation in human. Drug concentration in adipose tissue was found to be higher than those in other tissues, suggesting that adipose tissue plays a role as a storage tissue for the drug. Variations of metabolism in liver, body weight, and blood/plasma partition coefficient were found to be important factors affecting the plasma concentration profile of drug in human body.

• KSBB Journal
• /
• 제15권4호
• /
• pp.408-410
• /
• 2000

생리활성물질의 함유량이 많은 아가리쿠스버섯으로부터 초임계 유체 추출 기술을 이용하여 비극성 생리활성물질인 linoleic acid를 분리, 정제하였다. Gas chromatography - mass spectrometer를 이용하여 추출된 물질의 정성분석을 수행하여 추출된 물질은 약리작용 효과를 가지는 linoleic acid (cis-9, cis-12-octadecadienoic acid)로 분석되었다. 초임계 추출법을 이용한 아가리쿠스 버섯으로부터의 생리활성물질 추출공정의 최적화를 위하여 다양한 온도와 압력하에서 실힘을 수행하였으며 추출 효율을 비교한 결과 $50^{\circ}C, 200 kg_f/cm^2$의 최적 운전조건을 결정하였다.

• 한국지하수토양환경학회:학술대회논문집
• /
• 한국지하수토양환경학회 2003년도 추계학술발표회
• /
• pp.360-362
• /
• 2003

The adhesion of hydrocarbon degrading bacteria(HDB) differing in surface hydrophobicity was investigated. Cell wall hydrophobicity was modified chemically and physiologically. Modified adhesion deficient mutant of HDB was selected in a soil column assay Physiologically and chemical modification increased cell surface hydrophobicity. Cell surface charcteristis including BATH and zeta potential were measured. Physiological modification using ampicillin was not stable, but chemical modification was stabel. Hydrocarbon degrading potential was measured for modified and unmodifed HDB.

• 한국지하수토양환경학회:학술대회논문집
• /
• 한국지하수토양환경학회 2004년도 임시총회 및 추계학술발표회
• /
• pp.273-276
• /
• 2004

The adhesion of hydrocarbon degrading bacteria(HDB) differing in surface hydrophobicity was investigated. Cell wall hydrophobicity was modified chemically and physiologically. Modified adhesion deficient mutant of HDB was selected in a soil column assay. Physiologically and chemical modification increased cell surface hydrophobicity. Cell surface characteristics including BATH and FTIR were measured. Physiological modification using ampicillin was not stable, but chemical modification was stable. Hydrocarbon degrading efficiency was measured of TPH modified and unmodifed HDB.

• Archives of Pharmacal Research
• /
• 제10권4호
• /
• pp.250-257
• /
• 1987

The development of physiologically based pharmacokinetic model for drug distribution and excretion is described. The physiological modeling procedure is useful in animal and clinical applications to obtain fundamental knowledge of the transport and metabolism of a substance in vivo. In this paper a review of physiologically based pharmacokinetics is presented in the hope of understanding and increasing the use of this modelling technique. The method of model development and the composition of equations based on the different models are explained. For the better understanding a physiological pharmacokinetic model of tenoxicam disposition in the rat is presented as an example of flow limited model.

• 고려인삼학회:학술대회논문집
• /
• 고려인삼학회 1998년도 춘계총회 및 학술대회
• /
• pp.20-22
• /
• 1998